Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$6B |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$531M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$517M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$465M |
| 5 |
Palo Alto Networks
PANW
|
+$389M |
Top Sells
| 1 |
Tesla
TSLA
|
+$2.05B |
| 2 |
Apple
AAPL
|
+$1.89B |
| 3 |
Microsoft
MSFT
|
+$585M |
| 4 |
Amazon
AMZN
|
+$526M |
| 5 |
iShares MSCI EAFE Value ETF
EFV
|
+$414M |
Sector Composition
| 1 | Technology | 12.62% |
| 2 | Consumer Discretionary | 7.96% |
| 3 | Financials | 5.12% |
| 4 | Healthcare | 4.94% |
| 5 | Communication Services | 4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3076
Appian
APPN
$2.33B
| $801K | ﹤0.01% |
17,559
+834
| +5% | +$38K |
|
|
HIBB
3077
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $801K | ﹤0.01% |
16,851
-37,013
| -69% | -$1.76M |
|
3078
Kennametal
KMT
$1.57B
| $800K | ﹤0.01% |
32,137
-11,848
| -27% | -$295K |
|
3079
Denali Therapeutics
DNLI
$1.91B
| $799K | ﹤0.01% |
38,739
-34,061
| -47% | -$703K |
|
3080
International Seaways
INSW
$2.42B
| $797K | ﹤0.01% |
17,720
-110,310
| -86% | -$4.96M |
|
|
BFIT
3081
DELISTED
Global X Funds Global X Health & Wellness ETF
BFIT
| $797K | ﹤0.01% |
38,035
-51,719
| -58% | -$1.08M |
|
3082
Constellium
CSTM
$2.13B
| $797K | ﹤0.01% |
43,799
-29,755
| -40% | -$542K |
|
3083
Hope Bancorp
HOPE
$1.39B
| $796K | ﹤0.01% |
89,970
+44,079
| +96% | +$390K |
|
|
KFVG
3084
DELISTED
KraneShares CICC China 5G and Semiconductor Index ETF
KFVG
| $794K | ﹤0.01% |
53,056
+37,896
| +250% | +$567K |
|
3085
Cosan
CSAN
$2.77B
| $794K | ﹤0.01% |
58,393
-68,474
| -54% | -$931K |
|
3086
Triumph Financial, Inc.
TFIN
$1.36B
| $793K | ﹤0.01% |
12,241
-13,760
| -53% | -$892K |
|
|
AAA
3087
Alternative Access First Priority CLO Bond ETF
AAA
$42.6M
| $791K | ﹤0.01% |
31,776
-56,537
| -64% | -$1.41M |
|
3088
Innovator US Equity Power Buffer ETF September
PSEP
$891M
| $790K | ﹤0.01% |
24,398
+12,603
| +107% | +$408K |
|
3089
Goldman Sachs Access Emerging Markets USD Bond ETF
GEMD
$33.7M
| $790K | ﹤0.01% |
20,639
-66,694
| -76% | -$2.55M |
|
3090
ASE Group
ASX
$24.6B
| $788K | ﹤0.01% |
116,047
-12,508
| -10% | -$85K |
|
3091
Zentalis Pharmaceuticals
ZNTL
$102M
| $788K | ﹤0.01% |
39,277
+14,857
| +61% | +$298K |
|
3092
First Trust Long/Short Equity ETF
FTLS
$1.98B
| $787K | ﹤0.01% |
14,805
-12,402
| -46% | -$659K |
|
|
GLIF
3093
DELISTED
AGF Global Infrastructure ETF
GLIF
| $786K | ﹤0.01% |
33,208
+6,570
| +25% | +$156K |
|
3094
Sundial Growers
SNDL
$643M
| $785K | ﹤0.01% |
413,393
+305,094
| +282% | +$580K |
|
3095
FIS Christian Stock Fund
PRAY
$72M
| $784K | ﹤0.01% |
33,700
+12,635
| +60% | +$294K |
|
3096
Cheesecake Factory
CAKE
$2.71B
| $781K | ﹤0.01% |
25,767
+8,214
| +47% | +$249K |
|
3097
Fidelity MSCI Materials Index ETF
FMAT
$433M
| $780K | ﹤0.01% |
+17,649
| New | +$780K |
|
3098
FT Vest US Equity Moderate Buffer ETF July
GJUL
$610M
| $777K | ﹤0.01% |
+25,941
| New | +$777K |
|
|
INBX
3099
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $776K | ﹤0.01% |
42,315
-1,736
| -4% | -$31.9K |
|
3100
Allete
ALE
$3.72B
| $774K | ﹤0.01% |
14,663
+410
| +3% | +$21.6K |
|